Latest news with #Mairs&Power
Yahoo
07-05-2025
- Business
- Yahoo
Texas Instruments (TXN) Outperformed Amid Sector Weakness and Strategic Investments
Mairs & Power, an investment advisor, released the 'Mairs & Power Balanced Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertainty in March led to a fall in equities, while fixed income benefited from perceived safety. The fund ended the quarter up 0.04%. The fund outperformed the benchmark composite indexes (60% S&P 500 Total Return Index and 40% Bloomberg U.S. Government/Credit Bond Index), down 1.48%, and the Morningstar Moderate Allocation peer group, which fell 0.34%. In addition, please check the fund's top five holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as Texas Instruments Incorporated (NASDAQ:TXN). Texas Instruments Incorporated (NASDAQ:TXN) is a semiconductor manufacturer. The one-month return of Texas Instruments Incorporated (NASDAQ:TXN) was -4.96%, and its shares lost 12.43% of their value over the last 52 weeks. On May 6, 2025, Texas Instruments Incorporated (NASDAQ:TXN) stock closed at $161.09 per share with a market capitalization of $146.35 billion. Mairs & Power Balanced Fund stated the following regarding Texas Instruments Incorporated (NASDAQ:TXN) in its Q1 2025 investor letter: "Our preference for stable cash flow companies led to additional outperformance in the sector, with heavy overweights to Texas Instruments Incorporated (NASDAQ:TXN) and Motorola Solutions (MSI) benefiting relative returns. Texas Instruments has been on a multi-year business transition, investing heavily in semiconductor manufacturing facilities which are based in the U.S. Domestic facilities combined with general industrial end market weakness has kept the company from experiencing the same excitement as many of the other semiconductor companies." Texas Instruments Incorporated (TXN): Among the Best Dividend Stocks to Buy for Long-Term Passive Income A robotic arm in the process of assembling a complex circuit board - showing the industrial scale the company operates at. exas Instruments Incorporated (NASDAQ:TXN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 66 hedge fund portfolios held Texas Instruments Incorporated (NASDAQ:TXN) at the end of the fourth quarter compared to 57 in the third quarter. Texas Instruments Incorporated (NASDAQ:TXN) reported revenue of $4.1 billion in Q1 2025, an increase of 2% sequentially and 11% year over year. While we acknowledge the potential of Texas Instruments Incorporated (NASDAQ:TXN) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
Yahoo
07-05-2025
- Business
- Yahoo
Bio Techne (TECH) Fell on Negative Funding Environment
Mairs & Power, an investment advisor, released the 'Mairs & Power Balanced Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertainty in March led to a fall in equities, while fixed income benefited from perceived safety. The fund ended the quarter up 0.04%. The fund outperformed the benchmark composite indexes (60% S&P 500 Total Return Index and 40% Bloomberg U.S. Government/Credit Bond Index), down 1.48%, and the Morningstar Moderate Allocation peer group, which fell 0.34%. In addition, please check the fund's top five holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as Bio-Techne Corporation (NASDAQ:TECH). Bio-Techne Corporation (NASDAQ:TECH), with a market capitalization of $7.544 billion, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets. The one-month return of Bio-Techne Corporation (NASDAQ:TECH) was -11.74%, and its shares lost 38.07% of their value over the last 52 weeks. On May 6, 2025, Bio-Techne Corporation (NASDAQ:TECH) stock closed at $47.72 per share. Mairs & Power Balanced Fund stated the following regarding Bio-Techne Corporation (NASDAQ:TECH) in its Q1 2025 investor letter: "Bio-Techne Corporation (NASDAQ:TECH) underperformed due to negativity around the funding environment for biopharmaceuticals and biotech research given recent federal funding cuts and a weak venture capital funding environment. We have taken advantage of the recent weakness to add to our Bio-Techne position." Is MKS Instruments Inc. (MKSI) the Best Scientific Instruments Stock to Buy Right Now? A scientist working on a complex photonics instruments in a sterile laboratory setting. Bio-Techne Corporation (NASDAQ:TECH) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 24 hedge fund portfolios held Bio-Techne Corporation (NASDAQ:TECH) at the end of the fourth quarter compared to 25 in the third quarter. In the second quarter of fiscal 2025, the company generated $297 million in revenues, up 9% year-over-year on both reported and organic basis. While we acknowledge the potential of Bio-Techne Corporation (NASDAQ:TECH) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
Yahoo
07-05-2025
- Business
- Yahoo
Abbott Laboratories (ABT) Continued Sixth Straight Quarter of Double-Digit Gains
Mairs & Power, an investment advisor, released the 'Mairs & Power Balanced Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertainty in March led to a fall in equities, while fixed income benefited from perceived safety. The fund ended the quarter up 0.04%. The fund outperformed the benchmark composite indexes (60% S&P 500 Total Return Index and 40% Bloomberg U.S. Government/Credit Bond Index), down 1.48%, and the Morningstar Moderate Allocation peer group, which fell 0.34%. In addition, please check the fund's top five holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as Abbott Laboratories (NYSE:ABT). Abbott Laboratories (NYSE:ABT) is a leading manufacturer of health care products. The one-month return of Abbott Laboratories (NYSE:ABT) was 4.74%, and its shares gained 26.80% of their value over the last 52 weeks. On May 6, 2025, Abbott Laboratories (NYSE:ABT) stock closed at $133.06 per share with a market capitalization of $231.503 billion. Mairs & Power Balanced Fund stated the following regarding Abbott Laboratories (NYSE:ABT) in its Q1 2025 investor letter: "The Fund's overweight to the Health Care sector significantly contributed to relative outperformance which was further aided by positive selection within the sector. Abbott Laboratories (NYSE:ABT), a long-term portfolio holding, had its sixth quarter in a row of double-digit organic growth, while the market is increasingly appreciating the new trajectory for the diversified healthcare company." Abbott Laboratories (ABT): Jim Cramer Calls It a 'Tour de Force' — Why He's Still Amazed at This Stock An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. Abbott Laboratories (NYSE:ABT) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 66 hedge fund portfolios held Abbott Laboratories (NYSE:ABT) at the end of the fourth quarter, compared to 63 in the third quarter. While we acknowledge the potential of Abbott Laboratories (NYSE:ABT) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In another article, we covered Abbott Laboratories (NYSE:ABT) and shared the list of stocks Jim Cramer talked recently. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors.
Yahoo
07-05-2025
- Business
- Yahoo
The Walt Disney Company (DIS) Faced Challenges as Parks' Business Expectations Declined
Mairs & Power, an investment advisor, released the 'Mairs & Power Balanced Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertainty in March led to a fall in equities, while fixed income benefited from perceived safety. The fund ended the quarter up 0.04%. The fund outperformed the benchmark composite indexes (60% S&P 500 Total Return Index and 40% Bloomberg U.S. Government/Credit Bond Index), down 1.48%, and the Morningstar Moderate Allocation peer group, which fell 0.34%. In addition, please check the fund's top five holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as The Walt Disney Company (NYSE:DIS). The Walt Disney Company (NYSE:DIS) is an entertainment company that operates through the Entertainment, Sports, and Experiences segments. The one-month return of The Walt Disney Company (NYSE:DIS) was 11.22%, and its shares lost 3.55% of their value over the last 52 weeks. On May 6, 2025, The Walt Disney Company (NYSE:DIS) stock closed at $92.17 per share with a market capitalization of $182.948 billion. Mairs & Power Balanced Fund stated the following regarding The Walt Disney Company (NYSE:DIS) in its Q1 2025 investor letter: "The Walt Disney Company (NYSE:DIS) also underperformed both the market and the sector as expectations for its economically sensitive parks business decline, although the company's underlying profitability has improved. Also, within the sector we have historically not held any of the telecom players who have had a more difficult time developing a sustainable competitive advantage." The Walt Disney Company (DIS): Among Billionaire Mario Gabelli's Large-Cap Stock Picks with Huge Upside Potential A packed theater of moviegoers watching a blockbuster film produced by the entertainment company. The Walt Disney Company (NYSE:DIS) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 108 hedge fund portfolios held The Walt Disney Company (NYSE:DIS) at the end of the fourth quarter compared to 76 in the third quarter. While we acknowledge the potential of The Walt Disney Company (NYSE:DIS) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In another article, we covered The Walt Disney Company (NYSE:DIS) and shared billionaire Mario Gabelli's large-cap stock picks with huge upside potential. ClearBridge Value Strategy initiated a position in The Walt Disney Company (NYSE:DIS) during Q1 2025. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors.
